Maharashtra, India

Suraj Tatyasaheb Gore

This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignees: Aurigene Oncology Limited, Olema Pharmaceuticals, Inc.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suraj Tatyasaheb Gore. Retrieved from https://idiyas.com/inventor/suraj-tatyasaheb-gore

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 6.4

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Suraj Tatyasaheb Gore: Innovator in KAT6A Inhibitors

Introduction

Suraj Tatyasaheb Gore is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways.

Latest Patents

One of his key patents is for acylsulfonamide KAT6A inhibitors. The present disclosure describes acylsulfonamide compounds of Formula (J), along with their pharmaceutically acceptable salts, compositions, methods, and uses. These compounds are believed to be therapeutically useful as KAT6A inhibitors, particularly in the treatment and/or prevention of diseases and disorders mediated by KAT6A in a subject. Suraj holds 1 patent in this area.

Career Highlights

Throughout his career, Suraj has worked with prominent companies in the pharmaceutical industry. He has been associated with Olema Pharmaceuticals, Inc. and Aurigene Oncology Limited, where he has contributed to various innovative projects.

Collaborations

Suraj has collaborated with several professionals in his field, including Brian R. Hearn and David C. Myles. These collaborations have further enhanced his research and development efforts.

Conclusion

Suraj Tatyasaheb Gore is a dedicated inventor whose work in KAT6A inhibitors showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic options in the treatment of various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…